Upgrade to SI Premium - Free Trial

Goldman Sachs Downgrades Intellia Therapeutics (NTLA) to Sell

February 28, 2025 7:03 AM
(Updated - February 28, 2025 7:06 AM EST)

Goldman Sachs analyst Salveen Richter downgraded Intellia Therapeutics (NASDAQ: NTLA) from ...

(Premium-only article. Please sign in or upgrade to SI Premium to view.)

Categories

Analyst Comments Downgrades

Next Articles